Russia Considers Ban on E-cigarette Additives: Industry Voices Concerns

Aug.09.2023
Russia Considers Ban on E-cigarette Additives: Industry Voices Concerns
Russia's Health Ministry is set to introduce a bill prohibiting certain additives in e-cigarettes, including nicotine salts and flavorings.

In a press conference, Artyom Metchelyov, Chairman of the Youth Policy Committee of the State Duma of Russia, announced that the Russian Ministry of Health will soon submit a bill to the Russian Cabinet for review, which aims to ban the use of additives in e-cigarettes.


This list of substances banned from increasing the appeal of nicotine-containing liquids includes:


Food additives, herbal flavoring agents, and their derivatives, including vanillin, cocoa and its derivatives, licorice, spices, and any natural flavorings are prohibited. Synthetic sugars and synthetic or natural sweeteners are also prohibited. Additionally, additives that enhance nicotine addiction, such as nicotine salts, ethanol, ammonium, and ammonia, are banned.


According to a report from the Russian newspaper "News Report" on August 8th, the Russian Union of Nicotine-Containing Product Industry (Союз предприятий индустрии никотиносодержащих изделий, abbreviated as СПИНИ) and the Professional Alliance of Participants in the Russian Market of Electronic Nicotine Systems (Профессиональный альянс участников русского рынка электронных никотиновых систем, abbreviated as ПАУРРЭНС) have sent a letter to Russian Finance Minister Anton Siluanov, requesting the removal of food flavorings and salt-based nicotine from the list of banned substances and additives.


This letter has received support from over 50 industry professionals and experts in the e-cigarette sector. Among them is Lev Grigoriev, Chairman of BABYLON, a leading e-cigarette compliant distributor in Russia, who also opposes the policy change.


Lev Grigoriev stated:


Flavorings are used in all e-cigarette liquids, many of which are not noticeable. Many flavorings are processed using technology and without them, the product would be unusable. In other words, it is illogical to completely ban all flavorings as there is no similar situation in the world.


The Ministry of Health recommends exclusively using liquid products containing propylene glycol and glycerol, much like suggesting a complete ban on all types of alcohol such as wine, liquor, brandy, and so on, and only utilizing pure ethanol.


The second recommendation concerns nicotine salts. What are nicotine salts? From a chemical standpoint, they are simply nicotine. So why does the Ministry of Health believe they can be addictive? Addiction is not caused by nicotine itself, but rather by its concentration.


The recommendation from the Ministry of Health is unlikely to solve the problem it claims to address - reducing the accessibility of nicotine products for minors and teenagers. Examples of similar bans include snus, a tobacco product in Sweden. Although snus is still available on the market, it is supplied illegally without the payment of taxes. This significantly impacts consumers who may be exposed to low-quality and unsafe products. Similarly, if the use of nicotine salts and flavorings is prohibited, the situation would likely be comparable.


What are the recommendations from industry experts regarding the market? It is not to completely ban all flavors, as e-cigarettes are composed of various substances.


Taking into account that minors make up approximately 11.2% of all e-cigarette consumers, we are actively striving to restrict accessibility to underage individuals. However, under the current circumstances, this measure would affect around 90% of adult users.


References:


[1] The business sector has requested not to ban the use of flavorings in vaping products. [2] Vape sellers are requesting not to ban flavorings.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
Product | KT&G to Launch lil Tonino Lamborghini in South Korea, Bringing 3-Second Heat-Up to New HTP Platform
Product | KT&G to Launch lil Tonino Lamborghini in South Korea, Bringing 3-Second Heat-Up to New HTP Platform
KT&G will launch the lil Tonino Lamborghini heated tobacco device in Seoul on September 15, 2026. The product introduces a new heating technology called Flashwave Heating, which uses microwaves to heat tobacco sticks internally and delivers a manufacturer-rated heat-up time of about three seconds. The device features an all-metal aluminum body, a color display and a dedicated GUI, and launches alongside a new line of NAU tobacco sticks that are incompatible with existing lil consumables. Korean media describe the product as KT&G's first new heated tobacco platform since lil AIBLE was introduced in 2022.
Aug.31
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22